Who owns LEAP THERAPEUTICS INC?
- Ticker: CYPH
- CUSIP Number: 52187k200
Tip: Access positions for across all investors
Analyze quarterly positions in Leap Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Leap Therapeutics stock
Who bought or sold LEAP THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 2.3M | $2.7M | 1770% | Dec 2025 |
|
| Vanguard Group | 2.1M | $2.5M | 83% | Dec 2025 |
|
| Simplify Asset Management | 1.9M | $2.2M | 92% | Dec 2025 |
|
| Susquehanna International | 1.1M | $1.3M | 1053% | Dec 2025 |
|
| Geode Capital Management | 530k | $615k | 70% | Dec 2025 |
|
| Group One Trading | 162k | $187k | 4138% | Dec 2025 |
|
| State Street Corporation | 140k | $163k | 12% | Dec 2025 |
|
| Texas Capital Bank Wealth Management Services | 104k | $121k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 100k | $45k | 141% | Sep 2025 |
|
| Northern Trust | 88k | $102k | 42% | Dec 2025 |
|
| Key Client Fiduciary Advisors | 85k | $98k | -39% | Dec 2025 |
|
| Citadel Advisors | 71k | $32k | -36% | Sep 2025 |
|
| Two Sigma Investments | 71k | $32k | 410% | Sep 2025 |
|
| Simplex Trading | 68k | $79k | 1243% | Dec 2025 |
|
| Qube Research & Technologies | 63k | $73k | 100% | Dec 2025 |
|
| HighTower Advisors | 51k | $59k | -95% | Dec 2025 |
|
| Sequoia Financial Advisors | 48k | $56k | 100% | Dec 2025 |
|
| Caitong International Asset Management | 38k | $44k | 100% | Dec 2025 |
|
| Toroso Investments | 35k | $41k | 100% | Dec 2025 |
|
| LPL Financial | 33k | $38k | -9% | Dec 2025 |
|
| UBS Group | 31k | $36k | 7686% | Dec 2025 |
|
| Jane Street | 15k | $17k | -91% | Dec 2025 |
|
| Tower Research Capital | 13k | $15k | 100% | Dec 2025 |
|
| Keystone Financial Group | 12k | $14k | 100% | Dec 2025 |
|
| IHT Wealth Management | 11k | $13k | 100% | Dec 2025 |
|
| Cetera Investment Advisers | 10k | $12k | 100% | Dec 2025 |
|
| William Blair $ Company | 10k | $4.5k | 0% | Sep 2025 |
|
| CNB Bank | 5.0k | $5.8k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 2.1k | $2.4k | 106% | Dec 2025 |
|
| Advisor Group Holdings | 1.9k | $2.1k | -2% | Dec 2025 |
|
| Huntington National Bank | 1.0k | $1.2k | 0% | Dec 2025 |
|
| Optima Capital | 798.00 | $925.999200 | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 227.00 | $102.989900 | 100% | Sep 2025 |
|
| Fortitude Family Office | 182.00 | $210.992600 | 100% | Dec 2025 |
|
| Hanson McClain Advisors | 135.00 | $157.005000 | 0% | Dec 2025 |
|
| Royal Bank of Canada | 130.00 | $0 | 30% | Sep 2025 |
|
| Tompkins Financial Corp | 120.00 | $138.996000 | 0% | Dec 2025 |
|
Who sold out of Leap Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Gilead Sciences | Sep 2025 | 5.3M | $2.4M |
| Acadian Asset Management | Sep 2025 | 1.2M | $560k |
| Hrt Financial | Sep 2025 | 119k | $53k |
| XTX Topco | Sep 2025 | 31k | $14k |
| ADAR1 Capital Management | Sep 2025 | 26k | $12k |
| Baird Financial | Sep 2025 | 20k | $9.1k |